dr. hammers on combinations of ido and pd-1 inhibitors in rcc
Published 6 years ago • 81 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:37
dr. hammers discusses combining ido and pd-1 inhibitors in rcc
-
1:21
dr. hammers on combination of vaccines and immune checkpoint inhibitors in rcc
-
1:51
dr. hammers on study of hyperacute renal immunotherapy in rcc
-
0:56
dr. hammers on next steps with immunotherapy in rcc
-
1:17
dr. hammers on the future of immunotherapy in rcc
-
1:21
dr. hammers on the long-term benefits of the checkmate-214 study in rcc
-
1:42
dr. hammers on combination strategies in kidney cancer
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
11:30
immune checkpoint inhibitors in combination therapy for rcc
-
1:20
dr. hammers on immunotherapy combinations in kidney cancer
-
7:18
how i use pd-1 inhibitors in rcc
-
2:09
dr. hammers discusses immunotherapy in rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
0:55
dr. luke discusses pd-1 plus ido inhibitors in melanoma
-
1:40
dr. luke on combining an ido inhibitor with nivolumab in advanced cancers
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
1:18
dr. hammers on challenges with car t-cell therapy in rcc
-
7:54
combination therapies in renal cell carcinoma
-
1:17
dr. hammers on the checkmate-214 study for rcc